Parand Darou Pharma

Parand Daro Pharmaceuticals, established in 2015, is a company with a knowledge-driven approach. It specializes in the manufacturing of narcotic medicinal substances. As the second private sector entity in Iran to be granted a license by the Food and Drug Organization for the production of narcotic products, Parand Daro utilizes opioid raw materials to create potent medicinal substances such as codeine phosphate, noscapine, thebaine, papaverine, and oxycodone. In addition to meeting local demand, Parand Daro has diversified by exporting its products to international markets.